Literature DB >> 15493276

The effect of experimental haemocarbofiltration upon activity of mononuclear cells from normal and autoimmune patients.

S A Grando1, B T Glukhenky, G N Drannik, A P Kostromin, A B Romanenko.   

Abstract

We examined the functional activity of peripheral blood mononuclears (PBM) of 18 healthy subjects, 18 patients with pemphigus vulgaris, 12 with bullous pemphigoid and nine with discoid lupus erythematosus, after haemofiltration on carbon haemo-adsorbents of 'SKN' type. Proliferation in the response to PHA and Con A, for IL-1 and IL-2 production, and exogenous IL-2 absorption were assayed. The presence of IL-1 and IL-2 inhibitors in haemocarbo-adsorbent eluants was shown. We also investigated the natural killer (NK) and antibody-dependent cellular cytotoxic (ADCC) activities. We found significant increases of both lectin-dependent proliferation and of interleukin production by PBM of autoimmune patients after two to four perfusions. The ability of PBM to absorb IL-2 displayed a steady growth after each perfusion, whereas increase of NK and ADCC activities was observed after not less than six passes. The enhancement of PBM functional activity in autoimmune patients was accompanied by accumulation of IL-1 and IL-2 inhibitors in the sorbent. It was concluded that therapeutic effects of haemofiltration in autoimmune diseases involve improvement of immunocompetent cell function due to their deligandization by activated charcoal.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 15493276      PMCID: PMC1385133     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  Interleukin-2 production in bullous pemphigoid.

Authors:  A R Ahmed; K Hijri; V Arab-Kermani
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Isolation of human NK cells by density gradient centrifugation.

Authors:  T Timonen; E Saksela
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.

Authors:  D S Terman; G Buffaloe; C Mattioli; G Cook; R Tillquist; M Sullivan; J C Ayus
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

5.  Deficiency of interleukin-2 production and interleukin-2 receptor expression on peripheral blood leukocytes after phytohemagglutinin stimulation in pemphigus.

Authors:  V Kermani-Arab; K Hirji; A R Ahmed; J L Fahey
Journal:  J Invest Dermatol       Date:  1984-08       Impact factor: 8.551

6.  Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis.

Authors:  F E Berglöf; K Berglöf; D T Walz
Journal:  J Rheumatol       Date:  1978       Impact factor: 4.666

7.  Inhibition of postbinding target cell lysis and of lymphokine-induced enhancement of human natural killer cell activity by in vitro exposure to ultraviolet B radiation.

Authors:  C A Elmets; K Larson; G A Urda; B Schacter
Journal:  Cell Immunol       Date:  1987-01       Impact factor: 4.868

8.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

9.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.